This opportunity funds innovative translational research to understand the emergence and worsening of mood and psychotic disorders during the menopause transition. It supports studies on neurobiological and behavioral mechanisms, reproductive steroid roles, diagnosis, co-occurring symptoms, and psychosocial factors. Interdisciplinary collaboration and hypothesis-driven approaches are encouraged to advance novel treatment interventions.
Eligible applicants include a wide range of U.S. organizations such as government entities, educational institutions, nonprofits, small businesses, tribal organizations, and others. Specific eligibility details are provided in the funding announcement.
